CIRS is to host a PFAS-focused webinar, concentrating on the latest regulatory updates and compliance practices. This webinar is designed to help businesses promptly adapt to policy changes, fulfill compliance responsibilities robustly, and seize opportunities for sustainable development. Register now to solidify your compliance defenses and empower your business for the future!

As a fundamental chemical used in the production of polycarbonate plastics and epoxy resins, Bisphenol A (BPA, CAS No.: 80-05-7) is extensively utilized in plastic additives, coatings, and various other products. However, its endocrine-disrupting properties, reproductive toxicity, and potential immunological and developmental toxicities have raised health concerns. BPA can migrate into the human body through food contact materials and everyday items, posing significant risks, particularly to infants, pregnant women, and immunocompromised groups. Consequently, BPA has been included in the global regulatory focus list for stringent control.

A breakthrough study on the anti-photodamage effects of Gardenia Fructus Extracts, jointly conducted by Hangzhou CIRS KEXIN Biotech Co., Ltd. (CIRS Biotech) and Shanghai Junyu Biotechnology Co., Ltd. (Junyu Group), has been published in Cosmetics, an internationally renowned SCI-indexed journal. The breakthrough study provides scientific validation for the development of photoprotective ingredients and the establishment of its efficacy evaluation systems.

On August 1, 2025, the State Administration for Market Regulation (Standardization Administration of the People's Republic of China) officially approved and released the mandatory national standard GB 26572-2025 Requirements for Restricted Use of Hazardous Substances in Electrical and Electronic Products, which will come into effect on August 1, 2027. This standard is the first mandatory national standard in the field of China RoHS control, and its implementation will further deepen the restrictions on hazardous substances in electrical and electronic products.

Collaborative research on a hair heatrf damage model, jointly conducted by Hangzhou C&K Testing Technic Co., Ltd. (CIRS Testing) and Amway (Shanghai) Innovation and Science Co., Ltd. (Amway), has achieved significant progress. The findings have been formally published in the internationally authoritative SCI-indexed journal- Journal of Cosmetic Dermatology. This breakthrough study not only provides a novel scientific tool for in-depth exploration of hair heat damage mechanisms but also marks a new level of global recognition for China’s cosmetic efficacy evaluation technology within the international academic community.

Two-photon microscopy (TPM), a high-resolution three-dimensional imaging technology based on nonlinear optical effects, has demonstrated significant application potential in the field of cosmetic efficacy evaluation in recent years. Its core advantages lie in its non-invasive, in vivo, in situ, label-free real-time imaging capability, enabling deep observation of dynamic changes in cells and the extracellular matrix within skin tissue. This provides a scientific basis for evaluating the safety and efficacy of cosmetics.

On 25 July, 2025, the European Commission is set to hold a final vote on amendments to the REACH Regulation administrative fees by 30 August 2025. If passed, the revised regulation will take effect 20 days after publication in the EU Official Journal.

According to the EU MDR Regulation, Appendix I General Safety and Performance Requirements (GSPR) Article 10.4 regarding CMR/EDCs substances: The design and manufacture of medical devices should minimize the risk caused by substances or particles (including swarf, degradation products, and processing residues, etc.) that may be generated by the device. These substances mainly refer to CMR and EDCs substances.

On June 30, 2025, the Scientific Committee on Consumer Safety (SCCS) of the European Union issued scientific opinion(SCCS/1678/25) on Diethylamino Hydroxybenzoyl Hexyl Benzoate (DHHB) (CAS/EC No. 302776-68-7/443-860-6). Previously, on February 17, 2025, the SCCS published the scientific opinion on this substance which was open for comments. The scientific advice released this time is consistent with the assessment conclusions proposed during the comment phase and further confirms the maximum safe level and recommends the target maximal level of DnHexP as an impurity in DHHB.

On July 3, 2025, the Vietnam Ministry of Health issued Circular No. 34/2025/TT-BYT, proposing amendments to the cosmetic management regulations. The public consultation period is open until August 18, 2025.